Navigation Links
Japan Bioinformatics Announces the Release of their Simbiot® Time Course Analysis ‘How-To’ Guide
Date:2/19/2013

TOKYO, Japan (PRWEB) February 19, 2013

TOKYO, Japan – February 19, 2013 – Japan Bioinformatics, today announced the release of their Simbiot® Time Course Analysis ‘How-To’ Guide.

The increased efficiency and reduced per-read cost of next generation sequencing (NGS) devices has opened new and exciting opportunities for data analysis. Rather than using a small number of samples, sometimes without replicates, researchers can now effectively compare expression profiles of a large number of samples, complete with replicates.

While many effective and easy-to-use algorithms for gene expression analysis have been developed for handling microarray data, the process is not trivial and requires significant bioinformatics and IT expertise. The Simbiot® Time Course Analysis ‘How-To’ provides a step-by-step guide for handling data management and processing tools that can effectively transform the NGS data into a format that can be analyzed using more sophisticated algorithms.

The Simbiot® Time Course Analysis ‘How-To’ Guide uses a set of 12 NGS samples derived from the first 24 hours of Drosophila embryonic development to demonstrate an expression analysis method with peer-reviewed statistical algorithms. This approach offers a standardized analysis pipeline for expression data generated by high-speed sequencing technologies.

Download the complete Simbiot® Time Course Analysis ‘How-To’ Guide here.

About Japan Bioinformatics

Japan Bioinformatics KK is a Tokyo-based biotechnology company specializing in software development, as well as bioinformatics and information technology services to the life science community, including biotechnology, academia, research, pharmaceutical and bio-devices organizations.

They company's main product, Simbiot®, is a system for management and analysis of biological data. The application is available in a single-user, as well as a private server configuration that easily integrates into the client’s environment, including laboratory information management systems (LIMS), as well as custom and proprietary data formats, analytics and annotations. The system combines reliable data management, distribution, collaboration and analysis tools that support commercial and proprietary data formats, with specific focus on next generation sequencing (NGS) data.

In addition to software products, Japan Bioinformatics offers data analysis, bioinformatics and software development services. Learn more at http://www.japanbioinformatics.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10444186.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. WaferGen Bio-systems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
2. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
3. Japanese Universities Offered Access to SPIE Digital Library in Collaboration with JUSTICE
4. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
5. Sosei Group Corporation QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients and Filings in EU and Japan by End of Year
6. First Baby With Artificial Heart in Japan
7. Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
8. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
9. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
10. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
11. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -- Summary This report provides all the ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for ... recent study published in STEM CELLS suggests that human neural stem cell (hNSC) ... to produce more neural cells. , Strategies involving transplantation of these cells ...
(Date:3/28/2017)... Triangle Park, NC (PRWEB) , ... March 28, ... ... development company engaged in the development of a new orally administered treatment for ... Advisory Board. , CEO John Didsbury states, “As we seek to uniquely treat ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):